Twitter LinkedIn
    Thursday, June 8
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals»Perrigo to sell generic drugs business for $1.55 billion
    Deals

    Perrigo to sell generic drugs business for $1.55 billion

    March 2, 2021Updated:March 2, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Perrigo Company Plc on Monday posted quarterly earnings below estimates and said it would sell its underperforming generic drugs business for $1.55 billion, as the consumer healthcare products company sharpens focus on its core business.

    The sale, to private equity firm Altaris Capital Partners, is expected to close by the end of the third quarter, Perrigo said.

    “After the transaction closes, Perrigo expects to have more than $2 billion in cash available to advance its consumer self-care strategy, preferably through prudent and revenue accretive M&A,” Chief Executive Officer Murray Kessler said.

    Lower sales of Perrigo’s cold and cough products drove it to a net loss of $162.6 million in the fourth quarter versus a $146.1 million profit last year.

    Read More

    Source: Reuters

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Deal PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Brookfield buys KKR’s Spanish solar company stake

    March 23, 2023

    Ethical Capital Partners buys Pornhub for an undisclosed sum

    March 18, 2023

    EQT Infrastructure acquires Madison Energy Investments

    December 22, 2022

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    Comments are closed.

    Other Articles

    Blackstone Announces Appointment of Jeff Margolis, Leading Healthcare Information Technology Executive, as Senior Advisor

    January 16, 2021

    Novartis, staring down tough market for M&A, leans toward $25bn Sandoz spinoff

    July 4, 2022

    Asia M&A bonanza fuelled by Southeast Asia, private equity deals

    July 1, 2021

    Shell Agrees to Buy India’s Sprng Energy for $1.55 Billion

    April 29, 2022

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?